Nxstage Medical, Inc. (NXTM)

[surf1944]

7:30AM Nxstage Medical reports EPS in-line, revs in-line; guides Q2 EPS below consensus, revs in-line (NXTM) 10.68 : Reports Q1 (Mar) loss of $0.08 per share, in-line with the Capital IQ Consensus Estimate consensus of ($0.08); revenues rose 8.2% year/year to $61.6 mln vs the $61.1 mln consensus. Co issues guidance for Q2, sees EPS of ($0.07)-($0.08) vs. ($0.06) Capital IQ Consensus Estimate; sees Q2 revs of $64-65.5 mln vs. $64.75 mln Capital IQ Consensus Estimate.